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When estimating the average effect of a binary treatment (or exposure) on an
outcome, methods that incorporate propensity scores, the G‐formula, or
targeted maximum likelihood estimation (TMLE) are preferred over naïve
regression approaches, which are biased under misspecification of a parametric
outcome model. In contrast propensity score methods require the correct spec-
ification of an exposure model. Double‐robust methods only require correct
specification of either the outcome or the exposure model. Targeted maximum
likelihood estimation is a semiparametric double‐robust method that improves
the chances of correct model specification by allowing for flexible estimation
using (nonparametric) machine‐learning methods. It therefore requires weaker
assumptions than its competitors. We provide a step‐by‐step guided implemen-
tation of TMLE and illustrate it in a realistic scenario based on cancer epidemi-
ology where assumptions about correct model specification and positivity (ie,
when a study participant had 0 probability of receiving the treatment) are
nearly violated. This article provides a concise and reproducible educational
introduction to TMLE for a binary outcome and exposure. The reader should
gain sufficient understanding of TMLE from this introductory tutorial to be
able to apply the method in practice. Extensive R‐code is provided in easy‐to‐
read boxes throughout the article for replicability. Stata users will find a testing
implementation of TMLE and additional material in the Appendix S1 and at the
following GitHub repository: https://github.com/migariane/SIM‐TMLE‐
tutorial
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causal inference, ensemble Learning, machine learning, observational studies, targeted maximum
likelihood estimation
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1 | INTRODUCTION
During the last 30 years, modern epidemiology has been able to identify significant limitations of classic epidemiologic
methods when the focus is to explain the effect of a risk factor on a disease or outcome.1,2 In observational studies, treat-
ment groups are typically not directly comparable; thus, a careful statistical adjustment for confounders is necessary to
obtain unbiased exposure (or treatment) effect estimates. Failure to account for confounding variables, namely, those
preexposure variables associated with both the exposure and the outcome, can result in a biased estimate.3 Causal infer-
ence based on the Neyman‐Rubin potential outcome framework4 allows researchers to carefully adjust for confounders
under structural causal assumptions. The framework was first introduced in the social sciences by Rubin5 and later in
epidemiology and biostatistics by Greenland and Robins.6
Causal effects are often formulated in potential outcomes, as formalised by Rubin.4 Let A denote a binary exposure,
W a preexposure vector of potential confounders, and Y a binary outcome. Each individual has a pair of potential out-
comes: the outcome they would have received had they been exposed (A = 1), denoted Y(1), and the outcome had they
been unexposed, Y(0). However, it is only possible to observe a single realisation of the outcome for an individual. We
observe Y(1) only for those in the exposure group and Y(0) only for those in the unexposed group.4,5 Common causal
estimands of interest are the average treatment effect (ATE), defined as E[Y(1) − Y(0)], and the marginal odds ratio
(MOR), defined as E[Y(1)] × {1 − E[Y(0)]}/{E(1 − E[Y(1)]) × E[Y(0)]}.
To identify the ATE, classical epidemiologic methods, such as standard regression models where the treatment is
included as a covariate in the analysis, require the assumption that the effect measure of the treatment of interest is con-
stant across the levels of confounders included in the model.7 However, in observational studies, this is often not the
case. In 1986, a seminal paper6 demonstrated that under untestable causal assumptions (conditional exchangeability,
positivity, consistency, and noninterference), a consistent estimate of the ATE can be obtained by using the G‐formula6
(a generalisation of standardisation with respect to the confounder distribution):
ATE ¼ ∑
W
∑
y
P Y ¼ yjA ¼ 1;W ¼ wð Þ −∑
y
P Y ¼ yjA ¼ 0;W ¼ wð Þ
" #
P W ¼ wð Þ
G‐computation,8 based on the estimation of the components in the G‐formula, allows for a treatment effect that may
vary across the levels of the confounders. This approach relies on parametric modelling assumptions and bootstrap for
the estimation of the standard error. Therefore, G‐computation is sensitive to model misspecification9,10 and requires
time‐consuming estimation of confidence intervals (CIs).
Alternatively, the propensity score11 can also be used for estimation of the ATE. Propensity score methods, intro-
duced by Rosenbaum and Rubin,12 estimate the treatment mechanism. In our setting, where treatment is assigned at
a single time point, the propensity score is defined as the probability of being treated given the observed confounders
W, denoted P(A = 1|W). The propensity score is used to statistically balance exposure groups in their preexposure covar-
iates to estimate the ATE. This may be done via matching, weighting, or stratification.13,14 When weighting by the
inverse of the propensity score, extreme values of the propensity score can lead to large weights, resulting in unstable
ATE estimates with high variance (in particular, ATE estimates can fall outside the constraints of the statistical model).
Furthermore, when analysing observational data with a large number of variables and potentially complex relationships
among them, model misspecification is of particular concern in this case as well.10 Hence, correct model specification is
crucial to obtain unbiased estimates of the true ATE.10,14,15 Overall, the above‐mentioned methods can be classified as
those focused on modelling the outcome‐generating function of treatment and confounders (ie, G‐computation) and
those focused on modelling the treatment‐generating function of confounders (ie, propensity‐score methods).
Double‐robust methods were developed to minimise the impact of model misspecification.10,16,17 Double‐robust
methods require estimation of both the outcome and treatment mechanisms. For the estimation of the ATE in our exam-
ple, the outcome mechanism is the conditional expectation of the outcome given the exposure and the covariates,
denoted E(Y|A,W), and the treatment mechanism corresponds to the propensity score, which is the conditional proba-
bility of being treated given the observed confoundersW, denoted P(A = 1|W). Double‐robust means that the estimator
is consistent as long as either the outcome model or the treatment model is estimated consistently. Some double‐robust
estimators are also locally semiparametric efficient, meaning that the estimator has minimal large sample variance
among estimators that make the same model assumptions, under the correct specification of the required models.10,16,18
Current simulation‐based evidence shows that the use of double‐robust and locally efficient methods such as the aug-
mented inverse probability of treatment weighted (AIPTW) and the targeted maximum likelihood estimation (TMLE)
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method estimators often outperform the G‐computation and propensity score methods, in both point and interval esti-
mation.10,16,19 However, AIPTW is less robust to data sparsity and near violations of the practical positivity assumption
than TMLE (ie, when certain subgroups in a sample rarely receive some treatment of interest).10,16,19
Targeted maximum likelihood estimation, a general template for the construction of efficient and double‐robust sub-
stitution estimators, was first introduced by Van der Laan and Rubin in 200620 but is based on existing methods.18,21 This
approach first requires a specification of the statistical model, corresponding with what restrictions are being placed on
the data‐generating distribution. For the ATE, the TMLE procedure requires initial estimates of E(Y|A,W) and P(A = 1|
W), and then includes a substitution “targeting” step that optimises the bias‐variance tradeoff for the targeted parameter
(e.g., the ATE). Furthermore, one can readily use ensemble and machine‐learning algorithms to estimate E(Y|A,W) and
P(A = 1|W), thus avoiding model misspecification.10
Targeted maximum likelihood estimation respects the limits of the possible range of the targeted parameter, reduces
bias through the use of ensemble and machine‐learning algorithms, and, finally, makes statistical inference quick and
easy based on the efficient influence curve (IC).19,20,22,23 Evidence shows that TMLE can provide consistent ATE esti-
mates in challenging settings and has a smaller asymptotic variance compared with other (nonefficient) double‐robust
estimators.10,19,24 Mathematically, TMLE and AIPTW are both efficient and have the same asymptotic properties. In par-
ticular, they both have the minimum asymptotic variance in their class of semiparametric estimators. However, TMLE is
a substitution estimator and behaves differently in finite sample settings producing estimates in the range of values of the
parameter space while AIPTW does not.10,19,24
The statistical properties of TMLE make it a suitable tool for applied researchers aiming to estimate causal effects.
The TMLE procedure is available in standard statistical software such as the tmle package19 implemented in the statis-
tical software R (R Foundation for Statistical Computing, Vienna, Austria). Users familiar with other software can also
easily use TMLE, for example, by using our test version for a TMLE implementation in Stata or simply by importing their
data to R (see Appendix S1).
We provide a step‐by‐step guided implementation of TMLE by using a simulated example inspired by population‐
based cancer research.25 We aim to demystify TMLE and show applied medical statisticians how they can easily adopt
the method for their applications. In contrast to many other papers, we demonstrate the implementation of TMLE in
a realistic setting with many challenges such as near‐positivity violations (ie, manifested by large inverse probability
of treatment weights) and misspecification of both the treatment and outcome models. We also show the implementa-
tion of AIPTW and the benefit of incorporating advanced machine‐learning algorithms to reduce bias. We provide
commented R code embedded in boxes as well as Stata code in the Appendix S1, making our results fully reproducible.
2 | MOTIVATIONAL EXAMPLE, CAUSAL MODEL, AND DATA
GENERATION
The motivating example was developed to estimate the 1‐year mortality risk difference and odds ratio of death (Y) for
cancer patients treated with monotherapy (only radiotherapy; A = 1) versus dual therapy (treatment with radiotherapy
and chemotherapy; A = 0) while controlling for possible confounders (W).25,26 To be able to consistently estimate the
ATE, the data must satisfy the following assumptions: (i) Cancer treatment is independent of the potential mortality out-
comes after conditioning onW (ie, (Y(0), Y(1))⊥A|W). This assumption is often referred to as “conditional exchangeabil-
ity” and one cannot test it using the observed data. It implies that (within the strata of W) the mortality risk under the
potential treatment A = 1, ie, P(Y(1) = 1|A = 1,W) equals the one under treatment A = 0, ie, P(Y(1) = 1|A = 0,W). In
other words: the risk of death for those treated would have been the same as for those untreated if untreated subjects had
received, contrary to the fact, the treatment. This is equivalent to assuming that all confounders have been measured. (ii)
We also assume that within strata of W, every patient had a nonzero probability of receiving either of the 2 treatment
conditions, ie, 0 < P(A = 1|W) < 1 (positivity). (iii) We assume consistency, which states that we observe the potential
outcome corresponding with the observed treatment, ie, for any individual, Y = AY(1) + (1 − A)Y(0). Also, (iv) in defin-
ing an individual's counterfactual outcome as only a function of their own treatment, we assume noninterference, mean-
ing that the counterfactual outcome of one subject was not influenced by the treatment of any other. Under the causal
assumptions explained above, the ATE may be consistently estimated in the nonparametric model (that does not impose
assumptions on either E(Y|A,W) or P(A = 1|W)). Thus, if we believe these assumptions to hold and the sample size to be
sufficient, we may interpret our estimate of the ATE approximately as the marginal risk difference of 1‐year mortality for
cancer patients treated with monotherapy versus dual therapy.
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2.1 | Data generation process
To demonstrate the implementation of TMLE, we generated data, denoted as the set of i.i.d variables O = (W = (W1,W2,
W3, W4), A, Y), based on the directed acyclic graph
1 illustrated in Figure 1.
Briefly, sex (W1) and age category (W2) were generated as Bernoulli variables with probabilities 0.5 and 0.65, respec-
tively. Cancer stage (W3) and comorbidities (W4) were generated as ordinal variables with 4 and 5 levels, respectively. For
both variables, we used a random uniform distribution with minimum 0 and maximum 4 and 5, respectively, and
rounded the generated numbers off to the closest integer. The treatment variable (A) and the potential outcomes
(Y(1) and Y(0)) were generated as binary indicators using log‐linear models. In the treatment and outcome models,
we included an interaction term between age (W2) and comorbidities (W4) based on plausible biological mechanisms
such as an increased risk of comorbidities among older adults.26 Another, more complex data generating process can
be found in Appendix S1.
The data‐generating model for the treatment was selected to create the potential for near‐practical positivity viola-
tions. In particular, given the possible covariate values and the coefficients, the minimum possible true probability of
receiving treatment was 0.002. Finally, for simplicity, we did not include effect modification (ie, interaction between
A and W) though both TMLE and AIPTW can easily handle this setting as well.
First, we generated a sample of 5 million patients to estimate the true ATE and MOR. Afterwards, we generated a
sample of 10 000 patients used to illustrate the implementation of the algorithm and run simulations. In Box 1, we intro-
duce the specifications for the data generation and the true values for the ATE and the MOR. The true ATE implies that
the risk of death among cancer patients treated with monotherapy is approximately 19.3% higher than for those treated
with dual therapy. The true MOR implies that there is a 2.5 times higher odds of death among cancer patients treated
with monotherapy versus dual therapy. Note that for educational purposes, we present the code and results for a single
dataset simulated by our data‐generating mechanism. However, at the end of the illustration, we also present the results
of 1000 Monte Carlo simulations with a sample size of 1000 patients aiming (i) to estimate the bias of the estimators
under near‐positivity violations and mild misspecification of the treatment and outcome models and (ii) to demonstrate
TMLE's double‐robustness property by misspecifying the model for the outcome.
FIGURE 1 Direct acyclic graph. Legend: Conditional exchangeability of the treatment effect or exposure (A) on cancer mortality (Y) is
obtained through conditioning on a set of available covariates (Y(1),Y(0) ⊥ A|W). The average treatment effect for the structural
framework is estimated as the average risk difference between the expected effect of the treatment conditional on W among those treated
(E(Y|A = 1; W)) and the expected effect of the treatment conditional on W among those untreated (E(Y|A = 0; W)). Y: mortality binary
indicator (1 death, 0 alive), A: binary treatment for cancer with monotherapy versus dual therapy (1 Mono; 0 Dual); W: W1: sex; W2: age at
diagnosis; W3: cancer stage, TNM classification; W4: comorbidities [Colour figure can be viewed at wileyonlinelibrary.com]
Box 1 Data generation
# Function to generate data
generateData <- function(n) {
w1 <- rbinom(n, size = 1, prob = 0.5)
w2 <- rbinom(n, size = 1, prob = 0.65)
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In Box 1, plogis(x) represents the inverse logit function:
exp xð Þ
1þ exp xð Þ.
3 | TMLE ALGORITHM: GUIDED IMPLEMENTATION
In this section, we introduce the step‐by‐step implementation of the TMLE algorithm in a set of 10 boxes with docu-
mented R code for educational reproducibility.
3.1 | TMLE implementation
Targeted maximum likelihood estimation can either be used by means of the tmle function from the R‐package tmle or
by computing the algorithm in 6 steps manually. We first show the latter option for educational purposes; a sound under-
standing of TMLE will enable the reader to make the right decisions for their analysis.
First step: Prediction of the outcome model bar Q
0
(A,W) = E(Y|A,W)
The superscript 0 in Q
0
A;Wð Þ indicates that it is the initial estimate of E(Y|A,W), which is the conditional mean of
the outcome (Y) given treatment A and baseline covariatesW. To obtain Q
0
(A,W), we can use a standard logistic regres-
sion model:
logit P Y ¼ 1jA;Wð Þ½  ¼ β0 þ β1Aþ βT2 W
where logit(x) represents the function log
x
1‐x
 
and β is the vector of the estimates for the coefficients of the model
parameters. As before, A represents the treatment and W is the transpose of the vector of covariates W = (W1, …, W4)
presented in the DAG (Figure 1).
w3 <- round(runif(n, min = 0, max = 4), digits = 0)
w4 <- round(runif(n, min = 0, max = 5), digits = 0)
A <- rbinom(n, size = 1, prob = plogis(-5 + 0.05*w2 + 0.25*w3 + 0.6*w4 + 0.4*w2*w4))
# counterfactual
Y.1 <- rbinom(n, size = 1, prob = plogis(-1 + 1 - 0.1*w1 + 0.35*w2 + 0.25*w3 + 0.20*w4 + 0.15*w2*w4))
Y.0 <- rbinom(n, size = 1, prob = plogis(-1 + 0 - 0.1*w1 + 0.35*w2 + 0.25*w3 + 0.20*w4 + 0.15*w2*w4))
# observed outcome
Y <- Y.1*A + Y.0*(1 - A)
# return data.frame
data.frame(w1, w2, w3, w4, A, Y, Y.1, Y.0)
}
# True ATE and OR
set.seed(7777)
ObsData <- generateData(n = 5000000)
True_EY.1 <- mean(ObsData$Y.1)
True_EY.0 <- mean(ObsData$Y.0)
True_ATE <- True_EY.1 - True_EY.0; True_ATE
True_MOR <- (True_EY.1*(1 - True_EY.0))/((1 - True_EY.1)*True_EY.0); True_MOR
#True_ATE: 19.3%
#True_MOR: 2.5
# Data for simulation
set.seed(7722)
ObsData <- generateData(n = 10000)
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Therefore, we can estimate the initial probabilities as the prediction of this logistic outcome regression model for
A = 0 and A = 1, respectively (Box 2):
Q
0
0;Wð Þ ¼ expit bβ0 þ bβ10þ bβT2 W  and
Q
0
1;Wð Þ ¼ expit bβ0 þ bβ11þ bβT2 W ;
where expit(x) represents the inverse logit function
exp xð Þ
1þ exp xð Þ.
Note that for educational purposes, we misspecified both the propensity score and outcome models by not accounting
for the interaction between age (W2) and comorbidities (W4). This allows us to later show the added value of incorporat-
ing machine‐learning algorithms for prediction.
As computed at the bottom of Box 2, the G‐computation (untargeted) estimate is the mean of Q
0
1;Wð Þ − Q0 0;Wð Þ,
taken over all subjects. In this case, this is a very good estimate of the ATE and the MOR because the outcome model is
nearly correctly specified.
Second step: Prediction of the propensity score bg A;Wð Þ
In this step, we estimate P(A = 1|W), the probability of the treatment with monotherapy versus dual therapy (A)
given the set of covariates (W), namely, the propensity score. Using a logistic regression model, we set
logit P A ¼ 1jWð Þ½  ¼ α0 þ αT1W:
We then estimate the probabilities bg 1;Wð Þ using
bg 1;Wð Þ ¼ expit bα0 þ bαT1 W 
where bα0 and bα1 are the estimates of the coefficients in the logistic regression.
Box 2 Prediction of Q
0
A;Wð Þ
#First estimation of E(Y|A, W), namely Q
0
A;Wð Þ
m <- glm(Y ~ A + w1 + w2 + w3 + w4, family = binomial, data = ObsData) #Misspecified model
#Prediction for A, A = 1 and, A = 0
QAW = predict(m, type = "response")
Q1W = predict(m, newdata = data.frame(A = 1, ObsData[,c("w1","w2","w3","w4")]), type = "response")
Q0W = predict(m, newdata = data.frame(A = 0, ObsData[,c("w1","w2","w3","w4")]), type = "response")
#Estimated mortality risk difference (G‐computation)
mean(Q1W - Q0W)
#Initial ATE estimate: 20.4%
#Estimated MOR (G-computation)
mean(Q1W)*(1 - mean(Q0W)) / ((1 - mean(Q1W))*mean(Q0W))
#Initial MOR estimate: 2.7
Box 3 Prediction of the propensity score bg 1;Wð Þ
psm <- glm(A ~ w1 + w2 + w3 + w4, family = binomial, data = ObsData) #Misspecified model
gW = predict(psm, type = "response") #propensity score values
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Note that as in the previous step, here in Box 3, we intentionally did not account for the interaction between age (W2)
and comorbidities (W4) in the treatment model. Also, the summary of the estimated propensity score (gW) indicates near
violations of the practical positivity assumption given the very small numbers for the lower tail of the distribution, an
interesting setting under which to compare TMLE with AIPTW.
The next 2 steps aim to improve the prediction model Q
0
A;Wð Þ from step 1 by incorporating information from the
propensity score. This can be viewed as updating Q
0
A;Wð Þ along a path to incorporate additional information from the
propensity score function with the goal of reducing the residual confounding in the first estimate of Q
0
A;Wð Þ.
Third step: The clever covariate and estimation of ε
This step aims to compute the clever covariates H(1, W) and H(0, W), and a vector fluctuation parameter called ε.
The clever covariates in Equation 1 are calculated for each individual in the data, based on their previously estimated
probabilities of exposure status, P(A = 1|W) and P(A = 0|W). Note that the functional forms of the clever covariates
are very similar to inverse probability of treatment weights:
H 1;Wð Þ ¼ Abg 1;Wð Þ; H 0;Wð Þ ¼ 1‐Abg 0;Wð Þ: (1)
The fluctuation parameter bε ¼ bε0;bε1ð Þ is estimated through a maximum likelihood procedure; we set a model with
the observed outcome (Y) as dependent variable and the logit of the initial prediction of Q
0
A;Wð Þ as an offset (fixed
quantity) in an intercept‐free logistic regression with the clever covariates, H(1,W) and H(0,W) as independent variables
(Box 4):
E Y ¼ 1j A;Wð Þ εð Þ ¼ 1
1þ exp − log Q
0
A;Wð Þ
1−Q
0
A;Wð Þ
  − ε0H 0;Wð Þ − ε1H 1;Wð Þ
0@ 1A: (2)
When there is little variability inY−Q
0
A;Wð Þ (ie, the outcomeminus the offset), the fluctuation parameter will be esti-
mated as close to 0. In the absence of residual confounding, the propensity score does not provide additional information to
improve the initial estimate of Q
0
A;Wð Þ because Q0 A;Wð Þ was correctly specified. Given a misspecified Q0 A;Wð Þ;
the fluctuation parameter may also be estimated as approximately 0 when bg 1;Wð Þ has no supplementary information
relevant to Y. However, TMLE is consistent as long as either the model or the treatment model is estimated consistently.
The clever covariates are called “clever” because their form guarantees that the estimating equation corresponding to the
efficient IC is solved, which in turn yields desirable (asymptotic) inferential properties, including double‐robustness and
local efficiency. A complete explanation of how the clever covariates are chosen is given in van der Laan and Rose,10
Chapter 5.
In Box 4, we show how to compute the clever covariates and how to estimate ε. Note that qlogis(x) represents the
logit function in R.
Box 4 Computation of the clever covariates, H(1, W) and H(0, W), and estimation of bε
#Clever covariate and fluctuating/substitution parameters
H1W = (ObsData$A / gW)
H0W = (1 - ObsData$A) / (1 - gW)
#Propensity score distribution
summary(gW)
Min. 1st Qu. Median Mean 3rd Qu. Max.
0.002 0.03 0.086 0.155 0.240 0.718
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Alternatively, one could add the clever covariates not as covariates, but as weights in this same update step. This is
another valid targeted maximum likelihood estimator, based on a refined loss function (and parametric sub model), and
can improve stability.10
Fourth step: Update of Q
0
A;Wð Þ to Q1 A;Wð Þ
The updated estimate of E(Y|A,W) is denoted Q
1
A;Wð Þ. This update is performed by plugging inbε ¼ bε0;bε1ð Þ into the
following equations (Box 5):
Q
1
0;Wð Þ ¼ expit logit Q0 0;Wð Þ
 
þbε0=bg 0;Wð Þh i and Q1 1;Wð Þ ¼ expit logit Q0 1;Wð Þ þbε1=bg 1;Wð Þh i: (3)
In this way, the update is done separately under the treatment and under the control by evaluating both of these
expressions for all subjects.
Fifth step: Targeted estimate of the ATE and the MOR
Finally, the ATE and MOR are estimated as follows:
dATETMLE ¼ 1n Σni¼1 Q1 1;Wið Þ − Q1 0;Wið Þ and (4)
dMORTMLE ¼
1
n
Σni¼1Q
1
1;Wið Þ
 
x 1 −
1
n
Σni¼1Q
1
0;Wið Þ
  	
1 −
1
n
Σni¼1Q
1
1;Wið Þ
 
x
1
n
Σni¼1Q
1
0;Wið Þ
  	 ; (5)
where Wi denotes the ith individual's vector of covariates.
Table 1 shows the first 5 rows of the final dataset where the predicted value ofQ
1
1;Wð Þ−Q1 0;Wð Þ for the first patient
(id = 1) can be estimated by using Equation 3 as the inverse logit transformation of the initial estimates Q
0
1;Wð Þ and
Q
0
0;Wð Þ plus the estimated fluctuation parameter epsilon bεð Þ times the clever covariates as follows:
Box 5 Update from Q
0
to Q
1
and ATE and MOR estimates
Q0W_1 <- plogis(qlogis(Q0W) + epsilon[1] / (1 - gW))
Q1W_1 <- plogis(qlogis(Q1W) + epsilon[2] / gW)
ATEtmle1 <- mean(Q1W_1 - Q0W_1); ATEtmle1
EY1tmle1 <- mean(Q1W_1)
EY0tmle1 <- mean(Q0W_1)
MORtmle1 <- (EY1tmle1 * (1 - EY0tmle1)) / ((1 - EY1tmle1) * EY0tmle1); MORtmle1
#ATEtmle1: 22.1%
#Marginal Odds Ratio (MORtmle1): 3.0
epsilon <- coef(glm(ObsData$Y ~ -1 + H0W + H1W + offset(qlogis(QAW)), family = binomial)); epsilon
#epsilon: 0.003, 0.003
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Q
1
1;Wið Þ−Q1 0;Wið Þ ¼ plogis qlogis Q0 1;Wið Þ
 
þbε1=bg 1;Wið Þ −plogis qlogis Q0 0;Wið Þ þbε0=bg 0;Wið Þ  
plogis(qlogis(Q1W_0) + epsilon[2] / gW) − plogis(qlogis(Q0W_0) + epsilon[1] / (1‐gW)) = 0.1858
Sixth step: Statistical inference and 95% CI
Targeted maximum likelihood estimation constructs estimators based on the efficient IC,19,20 which can be used to
obtain standard errors. Based on semiparametric and empirical processes theory, the IC of a consistent and asymptoti-
cally linear estimator is derived in the gradient of the pathwise derivative of the target parameter such that27,28
dATE‐ATE ¼ 1
n
Σ
n
i¼1
ICi‐Op
1ﬃﬃﬃ
n
p
 
: (6)
By the weak law of the large numbers, the Op term in equation (6) converges to 0 at a rate of
1ﬃﬃﬃ
n
p as the sample size (n)
goes to infinity.10 The IC is a function of the data and the data‐generating components that one can derive for a given
model and target parameter that has mean 0 and finite variance. The central limit theorem applies so that in large sam-
ples, the variance of the estimator is thus the variance of the IC divided by n. While many influence functions and cor-
responding estimators exist for a given target parameter, there always exists an “efficient” IC that achieves the lower
bound on asymptotic variance for the given set of modelling assumptions. Targeted maximum likelihood estimation
and AIPTW are both constructed by using the efficient IC, making these estimators asymptotically efficient for the sta-
tistical model when all necessary models are correctly specified. For the ATE, the efficient IC is
EICATE ¼ AP A ¼ 1jWð Þ −
1−A
P A ¼ 0jWð Þ
 
Y−E YjA;Wð Þ½  þ E YjA ¼ 1;Wð Þ−E YjA ¼ 0;Wð Þ−ATE;
which can be evaluated as
dEICATE ¼ Abg 1;Wð Þ − 1−Abg 0;Wð Þ
 
Y−Q
1
A;Wð Þ
h i
þ Q1 1;Wð Þ−Q1 0;Wð Þ−dATETMLE (7)
for every subject. Using the resulting vector, the estimation of the standard error for dATETMLE is done as follows:
bσATE;TMLE ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃdVar dEICATE 
n
vuut
; (8)
where dVar dEICATE  represents the “sample variance” of the estimated IC.
TABLE 1 Final dataset for the update of Q0 A;Wð Þ to Q1 A;Wð Þ
id Q1W0 Q0W0 gW Epsilon 1 Epsilon 2 Q
1
1;Wið Þ−Q1 0;Wið Þ
1 0.8551 0.6702 0.1967 0.003 0.0027 0.1858
2 0.639 0.3787 0.0184 0.003 0.0027 0.2927
3 0.7494 0.5073 0.0509 0.003 0.0027 0.2511
4 0.6604 0.4011 0.0095 0.003 0.0027 0.3187
5 0.9152 0.7879 0.5908 0.003 0.0027 0.1264
… … … … … … …
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Based on the functional Delta method,29 the efficient IC for the MOR is
EICMOR ¼ 1−E Y 0ð Þ½ 
1−E Y 1ð Þ½ ð Þ2x E Y 0ð Þ½  ×D1 −
E Y 1ð Þ½ 
1−E Y 1ð Þ½ ð Þx E Y 0ð Þ½ ð Þ2 ×D0; (9)
where D1 and D0 are the efficient IC for E[Y(1)] and E[Y(0)], respectively:
D1 ¼ A
P A ¼ 1jWð Þ
 
Y−E YjA ¼ 1;Wð Þ½  þ E YjA ¼ 1;Wð Þ−E Y 1ð Þ½ ; (10)
D0 ¼ 1−A
P A ¼ 0jWð Þ
 
Y−E YjA ¼ 0;Wð Þ½  þ E YjA ¼ 0;Wð Þ−E Y 0ð Þ½ : (11)
In Box 6, it is shown how to evaluate the efficient IC for the ATE and the MOR based on Equations 5 to 11.
3.2 | Comparative performance of TMLE: TMLE vs naïve logistic regression approach and
AIPTW
In Box 7, we show the estimation and results of the naïve logistic regression approach, which assumes a correctly spec-
ified parametric outcome model (violated in the example below) and a constant effect of the treatment (A) on 1‐year
mortality (not violated in the example below). In addition, because of the noncollapsibility of the odds ratio, even a cor-
rectly specified logistic regression model generally does not produce estimates of the MOR.
Box 6 Estimation of the SE and 95% CI for the dATETMLE and dMORTMLE
#ATE efficient influence curve (EIC)
D1 <- ObsData$A/gW*(ObsData$Y - Q1W_1) + Q1W_1 - EY1tmle1
D0 <- (1 - ObsData$A)/(1 - gW)*(ObsData$Y - Q0W_1) + Q0W_1 - EY0tmle1
EIC <- D1 - D0
#ATE variance
n <- nrow(ObsData)
varHat.IC <- var(EIC)/n
#ATE 95%CI
ATEtmle1_CI <- c(ATEtmle1 - 1.96*sqrt(varHat.IC), ATEtmle1 + 1.96*sqrt(varHat.IC)); ATEtmle1;
ATEtmle1_CI
#ATEtmle1_CI(95%CI): 22.1% (15.1, 29.0)
#MOR EIC
EIC <- (1 - EY0tmle1) / EY0tmle1 / (1 - EY1tmle1)^2 * D1 - EY1tmle1 / (1 - EY1tmle1) / EY0tmle1^2 * D0
varHat.IC <- var(EIC)/n
#MOR 95%CI
MORtmle1_CI <- c(MORtmle1 - 1.96*sqrt(varHat.IC), MORtmle1 + 1.96*sqrt(varHat.IC)); MORtmle1;
MORtmle1_CI
#MORtmle1_CI(95%CI): 3.0 (1.6, 4.3)
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AIPTW, which directly uses the efficient IC, can also be used to estimate the ATE and the MOR. The ATE and MOR
using AIPTW are computed as follows:dEY1AIPTW ¼ 1n Σni¼1 I Ai ¼ 1ð Þbg 1;Wið Þ Yi − Q0 1;Wið Þ
 
þ Q0 1;Wið Þ
 	
:
dEY0AIPTW ¼ 1n Σni¼1 I Ai ¼ 0ð Þbg 0;Wið Þ Yi − Q0 0;Wið Þ
 
þ Q0 0;Wið Þ
 	
:
dATEAIPTW ¼ dEY1AIPTW − dEY0AIPTW: (12)
dMORAIPTW ¼ dEY1AIPTW 1 − dEY0AIPTW
 
1−dEY1AIPTW dEY0AIPTW ; (13)
where Wi denotes the ith individual's vector of covariates.
In Box 8, we provide code for the estimation of the ATE and the MOR (with variances and CIs) using AIPTW.
Box 7 Estimation of the conditional odds ratio using the naïve logistic regression approach
Naive <- glm(data = ObsData, Y ~ A + w1 + w2 + w3 + w4, family = binomial)
summary(Naive)
exp(Naive$coef[2])
exp(confint(Naive))
#Naïve OR (95%CI): 2.9 (2.5, 3.4)
Box 8 Estimation of the ATE and MOR using AIPTW
EY1aiptw <- mean((ObsData$A) * (ObsData$Y - Q1W) / gW + Q1W)
EY0aiptw <- mean((1 - ObsData$A) * (ObsData$Y - Q0W) / (1 - gW) + Q0W)
AIPTW_ATE <- EY1aiptw - EY0aiptw; AIPTW_ATE
AIPTW_MOR <- (EY1aiptw * (1 - EY0aiptw)) / ((1 - EY1aiptw) * EY0aiptw); AIPTW_MOR
#Calculation of the efficient IC
D1 <- (ObsData$A) * (ObsData$Y - Q1W) / gW + Q1W - EY1aiptw
D0 <- (1 - ObsData$A) * (ObsData$Y - Q0W) / (1 - gW) + Q0W - EY0aiptw
varHat_AIPTW <- var(D1 - D0) / n
ATEaiptw_CI <- c(AIPTW_ATE - 1.96*sqrt(varHat_AIPTW), AIPTW_ATE + 1.96*sqrt(varHat_AIPTW));
AIPTW_ATE; ATEaiptw_CI
#ATEaiptw_CI(95%CI): 24.0% (16.4, 31.6)
ICmor_aiptw <- (1 - EY0aiptw) / EY0aiptw / (1 - EY1aiptw)^2 * D1 - EY1aiptw / (1 - EY1aiptw) /
EY0aiptw^2 * D0
varHat_AIPTW2 <- var(ICmor_aiptw) / n
MORaiptw_CI <- c(AIPTW_MOR - 1.96*sqrt(varHat_AIPTW2), AIPTW_MOR + 1.96*sqrt(varHat_AIPTW2));
AIPTW_MOR; MORaiptw_CI
#MORaiptw_CI(95%CI): 3.4 (1.6, 5.2)
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3.3 | TMLE improved performance calling the Super‐Learner
Note that in the one‐sample simulation illustrated so far, we have intentionally misspecified both models (treatment and
outcome) to allow for evaluation of the benefit of calling the SuperLearner (SL) R package (Boxes 9 and 10). The SL,
which is a type of ensemble learner, adaptively combines different machine‐learning algorithms to (separately) estimate
Q
0
A;Wð Þ and bg A;Wð Þ. The aim of including this approach in the TMLE algorithm is to avoid bias arising from model
misspecification.10 SL thus replaces the simple logistic models in steps 1 and 2 above. One generally selects a set of pre-
diction algorithms for use in the SL, which may include parametric regression models, nonlinear regression models,
shrinkage estimators, and regression trees. Instead of choosing the algorithm with the smallest expected prediction error
(estimated by cross validation), the SL selects a weighted combination of different algorithms. Specifically, it selects the
weighted combination of predictions that minimises the cross‐validated mean square error (Supplementary Figure S1).30
It can be shown that this weighted combination will perform asymptotically at least as well as the best algorithm (in the
cross‐validated error), but typically even better.10,19,23,30 Box 9 describes the implementation of TMLE using the R‐pack-
age “tmle” while calling the SL. The basic implementation of TMLE in the R‐package tmle uses by default 3 algorithms:
“SL.glm” (logistic regression using A and W as covariates), “SL.step” (stepwise model selection of W in a generalized
linear model using Akaike's information criterion to determine subsets of the full model), and “SL.glm.interaction” (a
generalised linear model that includes all 2‐way interactions of the terms included in the full model).23 To list all imple-
mented algorithms, one can simply type “listWrappers()” in R. In Box 10, we illustrate the reduction of bias by calling, in
addition to default algorithms implemented in tmle, more advanced machine‐learning algorithms such as generalised
additive models, random forests, and recursive partitioning. For a more advanced theoretical background regarding
machine‐learning algorithms, see Hastie et al.31
Box 9 TMLE using default implementation with the default SL library
library(tmle)
library(SuperLearner)
TMLE2 <- tmle(Y = ObsData$Y, A = ObsData$A, W = ObsData[,c("w1", "w2", "w3", "w4")],
family = "binomial")
ATEtmle2 <- TMLE2$estimates$ATE$psi;ATEtmle2
TMLE2$estimates$ATE$CI
MORtmle2 <- TMLE2$estimates$OR$psi;MORtmle2
TMLE2$estimates$OR$CI
#ATEtmle2 (95%CI): 20.8% (17.5, 24.1)
#MORtmle2 (95%CI): 2.8 (2.3, 3.4)
Box 10 TMLE with a user‐selected SL library
library(tmle)
library(SuperLearner)
SL.library <- c("SL.glm","SL.step","SL.step.interaction", "SL.glm.interaction","SL.gam",
"SL.randomForest", "SL.rpart")
TMLE3 <- tmle(Y = ObsData$Y,A = ObsData$A,W = ObsData [,c("w1", "w2", "w3", "w4")],
family = "binomial", Q.SL.library = SL.library,g.SL.library = SL.library)
ATEtmle3 <- TMLE3$estimates$ATE$psi;ATEtmle3
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Table 2 summarises the results of 1000 Monte Carlo simulations each with a sample size of 1000 patients based on
the data generation process introduced in Box 1. We present the ATE and MOR estimates for 3 different estimators
(naïve regression, AIPTW, and TMLE) and 3 different versions of TMLE (TMLE‐1‐2‐3, Table 2) corresponding to the
usage of either logistic regressions or SL, implemented either with the default or user‐supplied library given in Box 10,
for the estimation of the outcome expectation and the propensity score. Furthermore, our data generation often pro-
duced near‐practical positivity violations (ie, certain subgroups in the samples rarely or never received treatment) as
described above. We checked the violation visually (Figure 2) and numerically, based on the empirical summary of
the propensity score distribution (mean = 0.189, min = 0.002 and max = 0.765). In the logistic regressions, the models
for the treatment and the outcome were misspecified by omitting the interactions between age and comorbidities.
Finally, to demonstrate the TMLE double‐robustness property, we ran a second set of simulations when correctly spec-
ifying the propensity score using the true logistic regression model (with the outcome model either incorrectly specified
with a main term logistic regression or adaptively estimated with SL). Complete details of the models' functional forms
for the data generation and the full settings for the simulation are provided in the Appendix S1 and at the following
GitHub repository: https://github.com/migariane/SIM‐TMLE‐tutorial, making our results fully reproducible.
TABLE 2 ATE and COR Monte Carlo simulations for mild misspecified models and near‐positivity violation, n = 1000
Misspecified treatment and outcome models Naïve AIPTW TMLE‐1 TMLE‐2 TMLE‐3
True ATE 0.193
Estimate ATE 0.208 0.199 0.193 0.193
Absolute bias ATE 0.015 0.006 0.000 0.000
Relative bias ATE (%) 7.2% 3.0% 0.0% 0.0%
True MOR 2.5
Estimate MOR 3.1 3.0 3.0 2.9 2.8
Treatment model correctly specified
True ATE 0.224
Estimate ATE 0.226 0.226 0.225 0.224
Absolute bias ATE 0.002 0.002 0.001 0.000
Relative bias ATE (%) 0.8% 0.8% 0.4% 0.0%
True MOR 2.6
Estimate MOR 2.9 2.8 2.8 2.8 2.7
dATE: Estimated average treatment effect from the 1000 simulation repetitions.dMOR: Estimated marginal odds ratio from the 1000 simulation repetitions.
Naïve: Logistic regression.
AIPTW: Augmented inverse‐probability treatment weights estimation under dual misspecification (model for the treatment and the outcome).
TMLE‐1: Dual misspecification. Algorithm computed by hand and naïve prediction (using from logistic regression models) without Super‐Learner (SL).
TMLE‐2: Dual misspecification. Algorithm estimated using R‐package tmle and default SL library (SL.glm, SL.step, and SL.glm.interaction).
TMLE‐3: Dual misspecification. Algorithm computed using R‐package tmle, user‐supplied SL library (SL.gam, SL.randomForest, and SL.rpart).
Treatment model correctly specified refers to the usage of the correct logistic regression model for the propensity score. For TMLE‐2 and TMLE‐3, SL is used to
estimate the outcome model as in the first scenario.
TMLE3$estimates$ATE$CI
MORtmle3 <- TMLE3$estimates$OR$psi;MORtmle3
TMLE3$estimates$OR$CI
#ATEtmle3 (95%CI): 20.7% (17.5, 24.0)
#MORtmle3 (95%CI): 2.7 (2.2, 3.3)
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In this example, the true ATE is 19.3% and the MOR of monotherapy versus dual therapy was 2.5. The results of the
different estimators are presented in Table 2. The naïve approach overestimated the MOR by 24%, whereas the AIPTW
and TMLE‐1 overestimated it by 20%, likely because of model misspecification. However, TMLE‐3, which used a more
diverse SL library, reduced the bias for the MOR to 12%. Regarding the simulation results for the risk differences, the
AIPTW estimator overestimated the ATE by 7%, whereas TMLE‐1 overestimated it by just 3%. However, TMLE‐2 and
TMLE‐3 reduced the bias for the ATE to 0%. Therefore, the introduction of machine‐learning algorithms and ensemble
learning as discussed above reduced the bias of TMLE‐2 and TMLE‐3. Finally, under misspecification of the outcome
model, but correct specification of the propensity score model, the TMLE‐3 was unbiased for the ATE and the MOR.
4 | DISCUSSION
The quantity, quality, and variety of available data for observational epidemiology continue to grow extensively, making
the estimation of causal effects more accessible and popular among applied statisticians and epidemiologists. Targeted
maximum likelihood estimation implemented with ensemble and machine‐learning algorithms has advantages over
other methods, but surprisingly there is limited guidance for the application of the technique for the estimation of the
ATE and MOR when dealing with binary outcomes.32 By using a reproducible example, we have demonstrated that
the implementation of the TMLE algorithm is not a black box. Using a guided step‐by‐step approach, we have provided
the basic elements needed to understand how TMLE works. Furthermore, we have demonstrated the positive benefit, in
bias reduction and performance, of adding more advanced machine‐learning algorithms to the fitting process of TMLE.
Our educational example adds to other already available tutorials,32-36 but with a different motivation based on popula-
tion‐based cancer epidemiology, a clear orientation towards applied statisticians, and fully explained and available code
to replicate step‐by‐step the implementation of TMLE in both Stata and R statistical software. However, our simulation
scenarios were relatively simple. We simulated categorical and binary variables and did not produce interaction between
the treatment and the vector of confounders, which might not be a realistic setting. Allowing for effect modification
(interaction between A andW) is an interesting case, because this is a specific setting where the naïve regression adjust-
ment does not work. Despite that, the main interest of the illustration was to introduce the step‐by‐step implementation
of the TMLE algorithm and demonstrate the added value of adding machine and ensemble learning algorithms for pre-
diction. Readers will find an additional example with treatment effect modification in Appendix S1 where we used the
R‐package simcausal.
FIGURE 2 Probability density function of the propensity score by treatment status for one randomly selected sample from 1000 Monte
Carlo simulations [Colour figure can be viewed at wileyonlinelibrary.com]
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The implementation of TMLE for the estimation of the ATE with a continuous outcome follows identical steps to
those listed above. However, note that for this case, (i) we first transform the outcome via Y − a/(b − a), where a and
b are plausible values for lower and upper limits of Y; (ii) proceed with the steps from the tutorial; and (iii) rescale
the estimate of the ATE and the variance at the end. Readers can find additional depth including the mathematical der-
ivation of TMLE in Chapter 7 of the Targeted Learning book.10
Adding more adaptive SuperLearner algorithms requires a significant amount of computer memory and computa-
tional time. Hence, with large sample sizes, such as those in population‐based cancer research, TMLE will benefit from
additional computing resources such as a cluster environment. For instance, for a computer with 1 core and 16 GB of
memory, the R‐package tmle took 5.4 minutes to estimate the ATE for 10 000 patients using more advanced
machine‐learning algorithms including generalised additive models, random forests, and boosting. Furthermore, some
machine‐learning algorithms will not work properly depending on the nature of the observed data (eg, for small sample
sizes or nonbinary outcomes). Moreover, some theoretical background knowledge of machine learning is required to
decide for the most adaptive SL algorithms.
Using TMLE in practical settings is similar to the strategy used for analysts when applying other double‐robust
methods such as AIPTW (eg, summarising the inverse probability of treatment weights, checking the distribution of
the weights by levels of the treatment, and considering if appropriate the truncation of the weights). Also, we suggest
considering the extent to which the data allow for very complicated machine‐learning algorithms, a question closely
related with the dimensionality of the data (ie, for small datasets and continuous outcomes, some machine learning
might not perform well). Finally, we suggest that readers aiming to develop TMLE approaches follow the causal
roadmap introduced above and described by Van der Laan and coauthors.10 Similarly, readers can find additional depth
including the mathematical derivation of TMLE in Chapter 5 of the Targeted Learning book.10
It is important to mention that TMLE is a general template for the construction of efficient substitution estimators
for a given estimation problem defined by a statistical model and a targeted parameter. Targeted maximum
likelihood estimation is a very active research area, and many advances have been and are currently being
made. Clearly, these advances have not been covered here in our introductory tutorial, but a reader might be
interested in such topics as the TMLE for rare outcomes,37 the Collaborative TMLE for the cross‐validated conditional
risk of a candidate estimator,38-40 and the TMLE for longitudinal settings where time‐dependent confounding is
an issue.34,41-43
In summary, we have provided an accessible presentation with documented code for implementing TMLE to esti-
mate the ATE and MOR for a binary outcome in observational studies. Given TMLE's appealing statistical properties,
we consider it a suitable method to be added to the analytical toolbox for estimation of causal effects in large popula-
tion‐based observational studies.
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